Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov;48(11):1654-1663.
doi: 10.1097/CCM.0000000000004597.

Management of Acute Ischemic Stroke

Affiliations
Review

Management of Acute Ischemic Stroke

Franziska Herpich et al. Crit Care Med. 2020 Nov.

Abstract

Objectives: Concise "synthetic" review of the state of the art of management of acute ischemic stroke.

Data sources: Available literature on PubMed.

Study selection: We selected landmark studies, recent clinical trials, observational studies, and professional guidelines on the management of stroke including the last 10 years.

Data extraction: Eligible studies were identified and results leading to guideline recommendations were summarized.

Data synthesis: Stroke mortality has been declining over the past 6 decades, and as a result, stroke has fallen from the second to the fifth leading cause of death in the United States. This trend may follow recent advances in the management of stroke, which highlight the importance of early recognition and early revascularization. Recent studies have shown that early recognition, emergency interventional treatment of acute ischemic stroke, and treatment in dedicated stroke centers can significantly reduce stroke-related morbidity and mortality. However, stroke remains the second leading cause of death worldwide and the number one cause for acquired long-term disability, resulting in a global annual economic burden.

Conclusions: Appropriate treatment of ischemic stroke is essential in the reduction of mortality and morbidity. Management of stroke involves a multidisciplinary approach that starts and extends beyond hospital admission.

PubMed Disclaimer

Conflict of interest statement

Dr. Rincon received funding from Bard, Portola Pharmaceuticals, and NeuroCrit, and he disclosed off-label product use of Targeted Temperature Management. Dr. Herpich has disclosed that he does not have any potential conflicts of interest.

Figures

Figure 1.
Figure 1.
Organization of stroke centers. EVT = endovascular therapy, IV tPA = IV tissue plasminogen activator.
Figure 2.
Figure 2.
Alberta Stroke Program Early CT Score (ASPECTS). Scoring for each of the 10 zones. Each zone is graded either 1 (normal) or 0 (abnormal). The sum of all zones gives the ASPECTS. A, Normal looking brain with ASPECTS = 10. B, Brain with ischemic changes and ASPECTS less than 6. C = caudate, Ic = internal capsule, In = insular cortex, M = middle cerebral artery, P = putamen.
Figure 3.
Figure 3.
CT-angiography demonstrating an abrupt occlusion of the patient’s left middle cerebral artery (arrow). L = left, R = right.
Figure 4.
Figure 4.
Mismatch ratio analysis of cerebral blood flow (CBF) by quantitative analysis of thresholds in time-to-maximum (T-max) to transit in a patient with a right middle cerebral artery occlusion. CBF in dark gray and T-max in light gray. A ratio of greater than 1.8 usually indicates eligibility for endovascular therapy. RAPID = rapid processing of perfusion and diffusion image analysis system.

Comment in

References

    1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333:1581–1587 - PubMed
    1. Prabhakaran S, Ruff I, Bernstein RA. Acute stroke intervention: A systematic review. JAMA. 2015; 313:1451–1462 - PubMed
    1. Jauch EC, Cucchiara B, Adeoye O, et al. Part 11: Adult stroke: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010; 12218 Suppl 3S818–S828 - PubMed
    1. Gyrd-Hansen D, Olsen KR, Bollweg K, et al. Cost-effectiveness estimate of prehospital thrombolysis: Results of the PHANTOM-S study. Neurology. 2015; 84:1090–1097 - PubMed
    1. Ebinger M, Kunz A, Wendt M, et al. Effects of golden hour thrombolysis: A Prehospital Acute Neurological Treatment and Optimization of Medical Care in Stroke (PHANTOM-S) substudy. JAMA Neurol. 2015; 72:25–30 - PubMed